Micro-RNA expression in cisplatin resistant germ cell tumor cell lines

Matthias Port1, Stephanie Glaesener, Christian Ruf

  • 1Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. matthias.port@web.de

Molecular Cancer
|May 18, 2011
PubMed
Abstract

Insights

This study identified key microRNAs (miRNAs) associated with cisplatin resistance in germ cell tumors. Upregulated miRNAs like miR-371-373 and miR-512-3p, and downregulated miRNAs such as miR-99a, offer new targets for overcoming drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Investigated microRNA (miRNA) expression patterns in cisplatin-resistant germ cell tumor (GCT) cell lines.
  • Aimed to elucidate mechanisms underlying cisplatin resistance in GCTs.

Purpose of the Study:

  • To compare miRNA expression profiles between cisplatin-sensitive and resistant GCT cell lines.
  • To identify specific miRNAs involved in conferring cisplatin resistance.

Main Methods:

  • Utilized three cisplatin-resistant GCT sublines and their sensitive parental counterparts.
  • Isolated total RNA and performed quantitative reverse transcription-polymerase chain reaction (qRT-PCR) using low-density arrays covering 738 human miRNAs.

Main Results:

  • Identified 72 differentially expressed miRNAs (9.8%) between sensitive and resistant cell lines, with most showing upregulation.
  • The miR-371-373 cluster and miR-520c/-520h were upregulated in resistant lines, potentially counteracting senescence and promoting differentiation.
  • New potential markers for cisplatin resistance, including upregulated hsa-miR-512-3p/-515/-517/-518/-525 and downregulated hsa-miR-99a/-100/-145, were identified.

Conclusions:

  • The miR-371-373 cluster is a promising target for understanding and potentially overcoming cisplatin resistance in GCTs.
  • Established a novel association between specific miRNA alterations (upregulation of hsa-miR-512-3p family, downregulation of hsa-miR-99a family) and cisplatin resistance.
  • Further functional studies are recommended to explore the role of these miRNAs in drug resistance mechanisms.